Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Christian Holm Hansen(Statens Serum Institut), Palle Valentiner‐Branth(Statens Serum Institut), Hanne‐Dorthe Emborg(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Astrid Blicher Schelde(Statens Serum Institut), Kåre Mølbak(Statens Serum Institut), Ida Rask Moustsen-Helm(Statens Serum Institut)
Cited by 162
Related Papers
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653
<i>Salmonella</i>Control Programs in Denmark
|Emerging infectious diseases|2003|343
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
|The Lancet Infectious Diseases|2022|218